Crossmark

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF-CRT) for locally advanced squamous cell carcinoma of the external auditory canal

Crossref DOI link: https://doi.org/10.1007/s00405-021-06974-4

Published Online: 2021-07-14

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shinomiya, Hirotaka https://orcid.org/0000-0003-1667-7545
Uehara, Natsumi

Fujita, Takeshi

Miyawaki, Daisuke

Imamura, Yoshinori

Teshima, Masanori

Kakigi, Akinobu

Kiyota, Naomi

Sasaki, Ryohei

Nibu, Ken-ichi
License Information

Text and Data Mining valid from 2021-07-14

Version of Record valid from 2021-07-14
More Information

Article History

Received: 10 April 2021

Accepted: 28 June 2021

First Online: 14 July 2021

Declarations

:

: All authors have no conflicts of interest to report.

: The trial was approved by the Institutional Review Board of the University of Kobe (#1385).

: All participants gave a written informed consent to participate and for publication.

Document is current

Any future updates will be listed below